Jason T Shackelford - Net Worth and Insider Trading
Jason T Shackelford Net Worth
The estimated net worth of Jason T Shackelford is at least $74 dollars as of 2025-07-19. Jason T Shackelford is the Prin Fin. & Acct. Officer of Oncternal Therapeutics Inc and owns about 140 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $74. Details can be seen in Jason T Shackelford's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason T Shackelford has not made any transactions after 2018-06-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason T Shackelford
Jason T Shackelford Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason T Shackelford owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Jason T Shackelford’s form 4 insider trades.
Insider Ownership Summary of Jason T Shackelford
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2018-06-20 | Principal Accounting Officer |
Jason T Shackelford Latest Holdings Summary
Jason T Shackelford currently owns a total of 1 stock. Jason T Shackelford owns 140 shares of Oncternal Therapeutics Inc (ONCT) as of June 20, 2018, with a value of $74.
Latest Holdings of Jason T Shackelford
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2018-06-20 | 140 | 0.53 | 74 |
Holding Weightings of Jason T Shackelford
Jason T Shackelford Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason T Shackelford has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the sale of 66 shares on June 20, 2018, which brought Jason T Shackelford around $176,394.
Insider Trading History of Jason T Shackelford
- 1
Jason T Shackelford Trading Performance
Jason T Shackelford Ownership Network
Ownership Network List of Jason T Shackelford
Ownership Network Relation of Jason T Shackelford
Jason T Shackelford Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Jason T Shackelford is the Principal Accounting Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Jason T Shackelford made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 10,980 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Jason T Shackelford Mailing Address
Above is the net worth, insider trading, and ownership report for Jason T Shackelford. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jason T Shackelford's mailing address is: Memphis` Tn 38139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
